Abstract Urinalysis is often interfered by vitamin C and PH. This study was to evaluate the interference of vitamin C and PH in urinalysis, and minimize the risk to make the effective communication. 732 leftover urine samples in which the concentration of vitamin C was 0.0 mmol/L and either of the test-strip results (Glucose, Blood, Bilirubin, Leucocyte, Nitrite, Protein, Ketone) was positive that were collected. The interference test checked out using these leftover urine samples. When the chemical protein module was positive, the sulfosalicylic acid test performed to confirm the positive results. About 27% of urine samples were vitamin C positive. Adequate vitamin C would interfere with the chemical result of GLU, BIL, and BLD, but not KET, PRO, WBC, NIT (p-value < 0.05). False-positive protein occurred at any samples, but higher when urine PH is greater than or equal to 8.0. In summary, to minimize the risk of vitamin C and PH in urinalysis, the laboratory should pay more attention to its conditions. Also, do more to help guarantee the accuracy of the urinalysis results and to give more comments to doctors to achieve effective communication.

ABSTRACT Objective: Nonalcoholic fatty liver disease is the commonest diffuse liver disease, of which women with polycystic ovary syndrome are at an increased risk. The aim of the present study was to assess the diagnostic value of the semiquantitative strain parameters of real-time ultrasound elastography for nonalcoholic fatty liver disease in patients with polycystic ovary syndrome. Subjects and methods: Thirty-five polycystic ovary syndrome patients with nonalcoholic fatty liver disease, 70 polycystic ovary syndrome patients without nonalcoholic fatty liver disease, and 70 healthy female controls of reproductive age were included. All participants underwent ultrasonic examination and semiquantitative analysis of real-time ultrasound elastography of the liver. Results: Main semi quantitative strain parameters, such as average strain value, differed significantly among groups polycystic ovary syndrome with nonalcoholic fatty liver disease, polycystic ovary syndrome without nonalcoholic fatty liver disease, and control (87.02 ± 10.16 vs. 96.31 ± 11.44 vs. 104.49 ± 7.28, p < 0.001). Clinical and laboratory parameters differed significantly between the two subgroups with low or high average strain value. For diagnostic value of average strain value for elevated aminotransferase, the area under the curve was 0.808 (range 0.721-0.895). In multiple linear regression analysis, polycystic ovary syndrome, waist circumference, and metabolic syndrome were stand-alone independent factors associated with average strain value among subjects without nonalcoholic fatty liver disease. Conclusion: Semiquantitative real-time ultrasound elastography analysis could distinguish liver parenchyma alterations in patients with polycystic ovary syndrome more sensitively. The diagnostic value of the proposed method for nonalcoholic fatty liver disease need further research.